These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24904576)

  • 1. Role of toll-like receptors in immune activation and tolerance in the liver.
    Nakamoto N; Kanai T
    Front Immunol; 2014; 5():221. PubMed ID: 24904576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.
    Seki E; Schnabl B
    J Physiol; 2012 Feb; 590(3):447-58. PubMed ID: 22124143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor signaling and liver fibrosis.
    Aoyama T; Paik YH; Seki E
    Gastroenterol Res Pract; 2010; 2010():. PubMed ID: 20706677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gut microbiota in liver diseases.
    Miyake Y; Yamamoto K
    Hepatol Res; 2013 Feb; 43(2):139-46. PubMed ID: 22970713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors in pathophysiology of liver diseases.
    Kiziltas S
    World J Hepatol; 2016 Nov; 8(32):1354-1369. PubMed ID: 27917262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease.
    Miura K; Ishioka M; Iijima K
    J Obes Metab Syndr; 2017 Jun; 26(2):86-96. PubMed ID: 31089501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors as adjuvant receptors.
    Kaisho T; Akira S
    Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease.
    Khanmohammadi S; Kuchay MS
    Pharmacol Res; 2022 Nov; 185():106507. PubMed ID: 36252773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases.
    Bruneau A; Hundertmark J; Guillot A; Tacke F
    Front Med (Lausanne); 2021; 8():725390. PubMed ID: 34650994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between gut microbiota and toll-like receptor: from immunity to metabolism.
    Yiu JH; Dorweiler B; Woo CW
    J Mol Med (Berl); 2017 Jan; 95(1):13-20. PubMed ID: 27639584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Toll-like receptors in health and diseases of gastrointestinal tract.
    Harris G; KuoLee R; Chen W
    World J Gastroenterol; 2006 Apr; 12(14):2149-60. PubMed ID: 16610014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics.
    de Kivit S; Tobin MC; Forsyth CB; Keshavarzian A; Landay AL
    Front Immunol; 2014; 5():60. PubMed ID: 24600450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection as a Trigger for Portal Hypertension.
    Steib CJ; Schewe J; Gerbes AL
    Dig Dis; 2015; 33(4):570-6. PubMed ID: 26159275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines.
    Faure-Dupuy S; Vegna S; Aillot L; Dimier L; Esser K; Broxtermann M; Bonnin M; Bendriss-Vermare N; Rivoire M; Passot G; Lesurtel M; Mabrut JY; Ducerf C; Salvetti A; Protzer U; Zoulim F; Durantel D; Lucifora J
    J Innate Immun; 2018; 10(4):339-348. PubMed ID: 29975940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.
    Szczepański M; Stelmachowska M; Stryczyński L; Golusiński W; Samara H; Mozer-Lisewska I; Zeromski J
    Eur Arch Otorhinolaryngol; 2007 May; 264(5):525-30. PubMed ID: 17165086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.